ESG Report 2022

2 In 2022, there were repeated waves of domestic outbreaks in reduce the economic burden of medication for diabetes patients, China. However, with continuous optimization and adjustment of and actively participate in multiple high-level medical academic the pandemic control policies, social production and life are forums and conferences to improve medical and health gradually recovering in an orderly manner. Being the leading standards. pharmaceutical company in China, The United Laboratories joins The Group considers its employees as the cornerstone of hands with all sectors and always shoulders the responsibility of development. We deeply understand the importance of talents safeguarding human health. However, under the common impact for corporate development and abide by the principle of “People- of the pandemic and climate change, ESG has gradually become oriented”. On the basis of protecting employees' safety, health a global consensus as the importance of ESG in corporate and legal rights, we have created a diversified employee training development growing. This year, we focus on green and development system to help employees of different positions development, health benefits, and employee care. Yet, we did or levels comprehensively upgrade their professional skills and not forget accomplishing our mission and responsibility. Guided integrative capabilities so as to mutually develop with the Group. by the direction of sustainability for business development, we We also care about employees' well-being. By organising actively engaged in charity and strive to establish an outstanding various activities, we allow employees to achieve work-life Chinese pharmaceutical brand. balance and increase their sense of belonging. We adhere to the Under the Country's strong promotion of carbon peak, carbon business principle of “Friendship, Equality, and Joint neutrality and ecological civilisation construction, the Group Development” and strengthen the management of supply chain adheres to the sustainable development philosophy of “Priority continuously. With efforts on enhancing the management of for Environmental Protection”, and the corporate philosophy of safety information and advocating on integrity, we strive to build “Love China, For China”. The Group supports the completion of a safe, sound and robust pharmaceutical brand. the national carbon market and clean power generation system, At the same time, the Group actively participates in social and cooperates with the comprehensive green transformation of welfare undertakings to serve the country. We have established the society, while maintaining the long-term development and the “United Laboratories Scholarships” in many colleges and operation of the Group. With the MSCI ESG rating remains at A universities across the Country to promote the development of level, leading the industry and winning honours in multiple ESG- medical education. At the same time, we have participated in the related evaluations, the Group will continue to promote the organisation of a number of professional academic activities to construction of green factories and contribute to the country's provide a learning platform for medical workers to communicate achievement of the goals of carbon peaking and carbon with each other. In addition, we also focus on social welfare such neutrality. as disaster relief, poverty alleviation and elderly care, and give In recent years, we have seen deepening reform of medical and back to society with real actions to fulfill our corporate social healthcare system. The United Laboratories insists on advancing responsibilities. with the times. In line with the corporate objective of “To Through the publication of the ESG report, The United Manufacture First-class Products, Provide First-class Services”, Laboratories hopes to deliver the Group's tenet of “To Make Life we improve the quality of products and services with the help of a More Valuable” and demonstrate the Group's efforts in fulfilling scientific management system, and enhance every aspect of its corporate social responsibilities. In the future, we will, as production and sales in pursuit of excellence. At the same time, always, cooperate with customers to create a win-win situation, the Group is committed to promoting the development of the create value with shareholders, and seek mutual development pharmaceutical industry by expanding its international business with employees to create benefits for society. We sincerely invite and increasing the number of products included in the National you to read this report, share your views with us, and walk hand Medical Insurance Drug List and National Essential Drug List to in hand with The United Laboratories. improve drug accessibility and affordability. We actively participate in the national centralised procurement of drugs to We believe that sound ESG governance is the key to the long-term development of an enterprise. Chairman Tsoi Hoi Shan About Us Environmental, Social and Governance Report 2022 The United Laboratories International Holdings Limited “ “ 2.1 Chairman Statement